The Bax mRNA in HF + GSPE group showed lower (p < 0.05) expression than that in NC + GSPE and HG treatments; moreover, the addition of GSPE in HF treatment observed the highest (p < 0.05) expression of Bcl-2 mRNA compared with the other three treatments. The gene discussed is BAX; the disease is hydrops fetalis.